	US 12,144,840 B2
	Method for treating or preventing benign prostatic hyperplasia
Kyung-Jae Kim, Guri-si (KR); Young-Cheon Song, Seoul (KR); Hyun-Seok Kong, Seoul (KR); and Jin-Man Kim, Yongin-si (KR)
Assigned to QUBEST BIO CO., LTD., Yongin-si (KR)
Filed by QUBEST BIO CO., LTD., Yongin-si (KR)
Filed on Aug. 3, 2021, as Appl. No. 17/392,498.
Application 17/392,498 is a continuation in part of application No. 16/621,808, abandoned, previously published as PCT/KR2017/009115, filed on Aug. 22, 2017.
Prior Publication US 2021/0379133 A1, Dec. 9, 2021
Int. Cl. A61K 36/285 (2006.01); A23L 33/00 (2016.01); A23L 33/10 (2016.01); A23L 33/105 (2016.01); A61K 31/343 (2006.01); A61P 13/08 (2006.01)

CPC A61K 36/285 (2013.01) [A23L 33/10 (2016.08); A23L 33/105 (2016.08); A23L 33/40 (2016.08); A61K 31/343 (2013.01); A61P 13/08 (2018.01); A23V 2002/00 (2013.01); A61K 2236/333 (2013.01)]

4 Claims

1. A method for treating benign prostatic hyperplasia comprising administering an effective amount of a composition consisting essentially of an Aucklandiae Radix extract as an active ingredient to a subject in need of treating or preventing benign prostatic hyperplasia.